Journal of Animal Reproduction and Biotechnology 2021; 36(4): 189-193
Published online December 31, 2021
https://doi.org/10.12750/JARB.36.4.189
Copyright © The Korean Society of Animal Reproduction and Biotechnology.
Changpa Institute, Daegu University, Gyeongsan 38453, Korea
Correspondence to: Kun Do Rhee
E-mail: kdrhee@daegu.ac.kr
Jak-STAT pathway is required for embryogenesis, female gametogenesis, cytokine-mediated neuroprotection, diabetes, obesity, cancer, stem cell, and various tissues. The noncanonical role of Jak-STAT in mitochondria function was supported by the detection of STAT protein in mitochondria, however, several studies show that STAT protein is detected in the endoplasmic reticulum (ER), and not in mitochondria. STAT protein may alter mitochondria function without entering mitochondria, this involves regulation of fission and fusion proteins to change mitochondria morphology. However, how changes in mitochondria morphology lead to changes in mitochondria metabolism needs further investigation.
Keywords: DRP1, fission, Jak-STAT, metabolism, mitochondria
Signal transducer and activator of transcription 3 (STAT3) is one of seven STAT proteins that was first identified as an interleukin-6 (IL-6) dependent transcription factor inducing acute phase gene expression (Zhong et al., 1994). It was cloned and initially named as acute-phase response factor (APRF) (Akira et al., 1994). STAT3 has an N-terminus domain, a coiled-coil domain, a DNA binding domain, a linker domain, an src homology 2 (SH2) domain, and a transactivation domain that contains tyrosine (Y705) and serine phosphorylation (S727) sites (Ihle, 1996). STAT3 are first tyrosine phosphorylated by receptor-associated Janus kinases (Jak), forms active dimers by Y705 binding to SH2 domain, and translocate to nucleus acting as a transcription factor to transcribe mitochondrial and metabolic genes as shown in Fig. 1 (Darnell et al., 1994; Schindler and Darnell 1995; Ihle, 1996; Levy and Lee 2002). In addition, STAT3 can be regulated by various post-translational modifications such as methylation, acetylation, and oxidation (Avalle and Poli 2018; Chun et al., 2020). Ablation of STAT3 results in embryonic lethality (Takeda et al., 1997) and expression of a constitutively active form of STAT3 (STAT3C) induces tumor formation (Bromberg et al., 1999). Disruption of Jak-STAT pathway shows its requirement in various tissues including female gametogenesis, embryogenesis, CNTF mediate neuroprotection in retinal degeneration, altered metabolism in an animal model of diabetes, and obesity (Levy and Lee 2002; Matthews and Febbraio 2008; Rhee et al., 2013; Sobinoff et al., 2013; Chowdhury et al., 2014; Gurzov et al., 2016). Thus, understanding the role of the Jak-STAT pathway in the regulation of mitochondria morphology and function may be crucial for finding treatments for infertility, neurodegenerative diseases, diabetes, obesity, and cancer. This review focuses on both the canonical and noncanonical role of the Jak-STAT pathway in mitochondrial morphology and metabolism.
In addition to the canonical role of STAT3 as a transcription factor, several studies report noncanonical localization and function in the mitochondria as shown in Fig. 1 (Gough et al., 2009; Wegrzyn et al., 2009; Szczepanek et al., 2011; Zhang et al., 2013; Macias et al., 2014; Luo et al., 2016; Avalle and Poli 2018; Chun et al., 2020; Mohammed et al., 2020). These studies show that S727 phosphorylated STAT3 is detected in mitochondria by fractionation, confocal imaging, EM imaging, and protection from proteinase K. Deletion of STAT3 results in a decrease of electron transport chain (ETC) complex activities and glycolytic activity in ras transformed cells (Gough et al., 2009; Wegrzyn et al., 2009). Immunoprecipitation of mitochondrial extracts shows that complex I interact directly with mitochondrial STAT3 (mitoSTAT3) (Wegrzyn et al., 2009). Alternatively, mitoSTAT3 can bind directly to mitochondria DNA (Harbauer et al., 2014). ChIP assay using STAT3 antibody shows that STAT3 binds directly with mitochondrial DNA (Vassilev et al., 2002; Macias et al., 2014). DNaseI footprinting/protection assay shows the identification of STAT3 consensus recognition sequences in the human mitochondrial transcriptome (Mercer et al., 2011). In addition, other members of the STAT family also show mitochondria localization (Meier and Larner, 2014). Both immunofluorescence and immunogold electron microscopy show that STAT6-GFP is also detected in mitochondria (Khan et al., 2013).
Despite studies showing mitochondrial localization, several studies argue against mitochondria localization. First, STAT3 lacks mitochondria localization signal (Harbauer et al., 2014; Wiedemann and Pfanner 2017; Su et al., 2020). Second, even STAT3 enters mitochondria, the stoichiometry of STAT3 to mitochondrial protein nor genome is different for direct interaction to occur (Phillips et al., 2010). Third, recent studies show that STAT3 may not be found in mitochondria (Avalle et al., 2019; Su et al., 2020). Sucrose gradient centrifugation shows that STAT3 is only detected in mitochondria-ER and not in the pure mitochondrial fraction (Su et al., 2020). Thus, the localization of STAT3 protein in the mitochondria needs to be reexamined using higher resolution immunofluorescence microscopy and a better fractionation technique.
If STAT protein does not enter mitochondria, how can the Jak-STAT pathway regulate mitochondria metabolism? Studies show that the Jak-STAT pathway may regulate mitochondria metabolism via STAT3’s canonical role as transcribing mitochondrial genes in the nucleus or act as a regulator of fission or fusion proteins to change mitochondrial morphology that alters cell metabolism as shown in Fig. 2. One of the phenotypes of STAT2 or STAT3 knockdown/knockout mice is the elongation of mitochondria (Shahni et al., 2015; Su et al., 2020). In cancer cells, proliferating cells show fragmented mitochondria morphology that exhibits the Warburg effect and the cells have diminished oxidative metabolism but increased glycolytic metabolism (Vander Heiden et al., 2009; Rafalski et al., 2012; Maycotte et al., 2017; Vaupel and Multhoff, 2021). The fragmented mitochondria morphology is not only limited to cancer, but also in proliferating stem cells. Embryonic stems cells (ESCs) maintain stemness and have fragmented mitochondrial morphology but change to elongated mitochondria morphology when it loses pluripotency during differentiation (Cho et al., 2006; Chung et al., 2007; Lee et al., 2020). Similar to cancer cells, the embryonic stem cells (ESCs) exhibit glycolytic metabolism but switch to oxidative metabolism upon differentiation (Chung et al., 2007; Kondoh et al., 2007). In addition, reprogrammed induces pluripotent stem (iPS) cells also switch from oxidative to glycolytic metabolism accompanied by mitochondrial fragmentation (Choi et al., 2015; Prieto et al., 2016).
How the Jak-STAT pathway regulates mitochondrial morphology is not clear. When mitochondria elongate upon withdrawal of leukemia inhibitory factor (LIF), dynamin-related protein 1 (DRP1) is decreased and fusion protein mitofusin 2 (MFN2) is increased, however other fusion/fission proteins mitofusin 1 (MFN1), optic atrophy protein 1 (OPA1), and mitochondrial fission 1 protein (FIS1) did not change (Lee et al., 2020). Knockdown of LIF receptor gp130 using RNA interference shows suppression of LIF induced DRP1 and FIS1, however, LIF induced DRP1 and FIS1 induction was inhibited by ERK1/2 inhibitor, but not by STAT3 small molecule inhibitor C188-9 (Cho et al., 2006; Prieto et al., 2016; Fix et al., 2019). Cytokines can activate other pathways such as ERK and AKT via crosstalk (Boulton et al., 1994; Dolcet et al., 2001; Ernst and Jenkins, 2004), thus it is possible that LIF mediated ERK pathway may contribute to fission, and the use of small-molecule inhibitors may have not fully perturbed Jak-STAT pathway. Whole exome sequencing in a human patient with mitochondrial fission disorder revealed homozygous STAT2 mutation that is unable to phosphorylate DRP1 emphasizing the importance of the Jak-STAT pathway in mitochondrial fission (Shahni et al., 2015). However other studies show that STAT3 interacts directly with OPA1 in mitochondria using STAT3 small molecule inhibitor Sttatic (Zhang et al., 2020; Brillo et al., 2021) or binds to OPA1 promoter to induce fusion rather than fission using shRNA STAT3 knockdown and ChIP assay (Nan et al., 2017) contradicting the role of Jak-STAT pathway in maintaining mitochondria fragmentation. Contradicting studies suggest that the role of the Jak-STAT pathway may change depending on the tissue and microenvironment, however, these studies show the importance of the Jak-STAT pathway in mitochondrial dynamics.
The noncanonical role of STAT protein in mitochondria is still controversial. Super-resolution imaging using 3D structure illumination microscopy (SIM) may help to detect STAT protein in the mitochondria. Whether the Jak-STAT pathway induces fission via DRP1 or fusion via OPA1 is also controversial. The role of the Jak-STAT pathway may change depending on the tissue specificity and microenvironment. Studies show a link between mitochondrial morphology and metabolism, however, how changes in mitochondrial morphology regulate glycolytic and oxidative metabolism needs to be examined. Understanding the role of the Jak-STAT pathway in the regulation of mitochondria morphology and function may be crucial to finding treatments and diagnostics for various diseases.
None.
Writing – original draft, K.D.R.; writing – review & editing, K.D.R.
This work was supported by the BK21 Four program and the Korea Evaluation Institute of Industrial Technology (KEIT; 20012411).
Not applicable.
Not applicable.
Not applicable.
Not applicable.
No potential conflict of interest relevant to this article was reported.
Journal of Animal Reproduction and Biotechnology 2021; 36(4): 189-193
Published online December 31, 2021 https://doi.org/10.12750/JARB.36.4.189
Copyright © The Korean Society of Animal Reproduction and Biotechnology.
Changpa Institute, Daegu University, Gyeongsan 38453, Korea
Correspondence to:Kun Do Rhee
E-mail: kdrhee@daegu.ac.kr
Jak-STAT pathway is required for embryogenesis, female gametogenesis, cytokine-mediated neuroprotection, diabetes, obesity, cancer, stem cell, and various tissues. The noncanonical role of Jak-STAT in mitochondria function was supported by the detection of STAT protein in mitochondria, however, several studies show that STAT protein is detected in the endoplasmic reticulum (ER), and not in mitochondria. STAT protein may alter mitochondria function without entering mitochondria, this involves regulation of fission and fusion proteins to change mitochondria morphology. However, how changes in mitochondria morphology lead to changes in mitochondria metabolism needs further investigation.
Keywords: DRP1, fission, Jak-STAT, metabolism, mitochondria
Signal transducer and activator of transcription 3 (STAT3) is one of seven STAT proteins that was first identified as an interleukin-6 (IL-6) dependent transcription factor inducing acute phase gene expression (Zhong et al., 1994). It was cloned and initially named as acute-phase response factor (APRF) (Akira et al., 1994). STAT3 has an N-terminus domain, a coiled-coil domain, a DNA binding domain, a linker domain, an src homology 2 (SH2) domain, and a transactivation domain that contains tyrosine (Y705) and serine phosphorylation (S727) sites (Ihle, 1996). STAT3 are first tyrosine phosphorylated by receptor-associated Janus kinases (Jak), forms active dimers by Y705 binding to SH2 domain, and translocate to nucleus acting as a transcription factor to transcribe mitochondrial and metabolic genes as shown in Fig. 1 (Darnell et al., 1994; Schindler and Darnell 1995; Ihle, 1996; Levy and Lee 2002). In addition, STAT3 can be regulated by various post-translational modifications such as methylation, acetylation, and oxidation (Avalle and Poli 2018; Chun et al., 2020). Ablation of STAT3 results in embryonic lethality (Takeda et al., 1997) and expression of a constitutively active form of STAT3 (STAT3C) induces tumor formation (Bromberg et al., 1999). Disruption of Jak-STAT pathway shows its requirement in various tissues including female gametogenesis, embryogenesis, CNTF mediate neuroprotection in retinal degeneration, altered metabolism in an animal model of diabetes, and obesity (Levy and Lee 2002; Matthews and Febbraio 2008; Rhee et al., 2013; Sobinoff et al., 2013; Chowdhury et al., 2014; Gurzov et al., 2016). Thus, understanding the role of the Jak-STAT pathway in the regulation of mitochondria morphology and function may be crucial for finding treatments for infertility, neurodegenerative diseases, diabetes, obesity, and cancer. This review focuses on both the canonical and noncanonical role of the Jak-STAT pathway in mitochondrial morphology and metabolism.
In addition to the canonical role of STAT3 as a transcription factor, several studies report noncanonical localization and function in the mitochondria as shown in Fig. 1 (Gough et al., 2009; Wegrzyn et al., 2009; Szczepanek et al., 2011; Zhang et al., 2013; Macias et al., 2014; Luo et al., 2016; Avalle and Poli 2018; Chun et al., 2020; Mohammed et al., 2020). These studies show that S727 phosphorylated STAT3 is detected in mitochondria by fractionation, confocal imaging, EM imaging, and protection from proteinase K. Deletion of STAT3 results in a decrease of electron transport chain (ETC) complex activities and glycolytic activity in ras transformed cells (Gough et al., 2009; Wegrzyn et al., 2009). Immunoprecipitation of mitochondrial extracts shows that complex I interact directly with mitochondrial STAT3 (mitoSTAT3) (Wegrzyn et al., 2009). Alternatively, mitoSTAT3 can bind directly to mitochondria DNA (Harbauer et al., 2014). ChIP assay using STAT3 antibody shows that STAT3 binds directly with mitochondrial DNA (Vassilev et al., 2002; Macias et al., 2014). DNaseI footprinting/protection assay shows the identification of STAT3 consensus recognition sequences in the human mitochondrial transcriptome (Mercer et al., 2011). In addition, other members of the STAT family also show mitochondria localization (Meier and Larner, 2014). Both immunofluorescence and immunogold electron microscopy show that STAT6-GFP is also detected in mitochondria (Khan et al., 2013).
Despite studies showing mitochondrial localization, several studies argue against mitochondria localization. First, STAT3 lacks mitochondria localization signal (Harbauer et al., 2014; Wiedemann and Pfanner 2017; Su et al., 2020). Second, even STAT3 enters mitochondria, the stoichiometry of STAT3 to mitochondrial protein nor genome is different for direct interaction to occur (Phillips et al., 2010). Third, recent studies show that STAT3 may not be found in mitochondria (Avalle et al., 2019; Su et al., 2020). Sucrose gradient centrifugation shows that STAT3 is only detected in mitochondria-ER and not in the pure mitochondrial fraction (Su et al., 2020). Thus, the localization of STAT3 protein in the mitochondria needs to be reexamined using higher resolution immunofluorescence microscopy and a better fractionation technique.
If STAT protein does not enter mitochondria, how can the Jak-STAT pathway regulate mitochondria metabolism? Studies show that the Jak-STAT pathway may regulate mitochondria metabolism via STAT3’s canonical role as transcribing mitochondrial genes in the nucleus or act as a regulator of fission or fusion proteins to change mitochondrial morphology that alters cell metabolism as shown in Fig. 2. One of the phenotypes of STAT2 or STAT3 knockdown/knockout mice is the elongation of mitochondria (Shahni et al., 2015; Su et al., 2020). In cancer cells, proliferating cells show fragmented mitochondria morphology that exhibits the Warburg effect and the cells have diminished oxidative metabolism but increased glycolytic metabolism (Vander Heiden et al., 2009; Rafalski et al., 2012; Maycotte et al., 2017; Vaupel and Multhoff, 2021). The fragmented mitochondria morphology is not only limited to cancer, but also in proliferating stem cells. Embryonic stems cells (ESCs) maintain stemness and have fragmented mitochondrial morphology but change to elongated mitochondria morphology when it loses pluripotency during differentiation (Cho et al., 2006; Chung et al., 2007; Lee et al., 2020). Similar to cancer cells, the embryonic stem cells (ESCs) exhibit glycolytic metabolism but switch to oxidative metabolism upon differentiation (Chung et al., 2007; Kondoh et al., 2007). In addition, reprogrammed induces pluripotent stem (iPS) cells also switch from oxidative to glycolytic metabolism accompanied by mitochondrial fragmentation (Choi et al., 2015; Prieto et al., 2016).
How the Jak-STAT pathway regulates mitochondrial morphology is not clear. When mitochondria elongate upon withdrawal of leukemia inhibitory factor (LIF), dynamin-related protein 1 (DRP1) is decreased and fusion protein mitofusin 2 (MFN2) is increased, however other fusion/fission proteins mitofusin 1 (MFN1), optic atrophy protein 1 (OPA1), and mitochondrial fission 1 protein (FIS1) did not change (Lee et al., 2020). Knockdown of LIF receptor gp130 using RNA interference shows suppression of LIF induced DRP1 and FIS1, however, LIF induced DRP1 and FIS1 induction was inhibited by ERK1/2 inhibitor, but not by STAT3 small molecule inhibitor C188-9 (Cho et al., 2006; Prieto et al., 2016; Fix et al., 2019). Cytokines can activate other pathways such as ERK and AKT via crosstalk (Boulton et al., 1994; Dolcet et al., 2001; Ernst and Jenkins, 2004), thus it is possible that LIF mediated ERK pathway may contribute to fission, and the use of small-molecule inhibitors may have not fully perturbed Jak-STAT pathway. Whole exome sequencing in a human patient with mitochondrial fission disorder revealed homozygous STAT2 mutation that is unable to phosphorylate DRP1 emphasizing the importance of the Jak-STAT pathway in mitochondrial fission (Shahni et al., 2015). However other studies show that STAT3 interacts directly with OPA1 in mitochondria using STAT3 small molecule inhibitor Sttatic (Zhang et al., 2020; Brillo et al., 2021) or binds to OPA1 promoter to induce fusion rather than fission using shRNA STAT3 knockdown and ChIP assay (Nan et al., 2017) contradicting the role of Jak-STAT pathway in maintaining mitochondria fragmentation. Contradicting studies suggest that the role of the Jak-STAT pathway may change depending on the tissue and microenvironment, however, these studies show the importance of the Jak-STAT pathway in mitochondrial dynamics.
The noncanonical role of STAT protein in mitochondria is still controversial. Super-resolution imaging using 3D structure illumination microscopy (SIM) may help to detect STAT protein in the mitochondria. Whether the Jak-STAT pathway induces fission via DRP1 or fusion via OPA1 is also controversial. The role of the Jak-STAT pathway may change depending on the tissue specificity and microenvironment. Studies show a link between mitochondrial morphology and metabolism, however, how changes in mitochondrial morphology regulate glycolytic and oxidative metabolism needs to be examined. Understanding the role of the Jak-STAT pathway in the regulation of mitochondria morphology and function may be crucial to finding treatments and diagnostics for various diseases.
None.
Writing – original draft, K.D.R.; writing – review & editing, K.D.R.
This work was supported by the BK21 Four program and the Korea Evaluation Institute of Industrial Technology (KEIT; 20012411).
Not applicable.
Not applicable.
Not applicable.
Not applicable.
No potential conflict of interest relevant to this article was reported.
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
pISSN: 2671-4639
eISSN: 2671-4663